salvage chemotherapy

sal·vage che·mo·ther·a·py

use of chemotherapy in a patient with recurrence of a malignancy following initial treatment, in hope of a cure or prolongation of life.
Synonym(s): salvage therapy (1)

salvage chemotherapy

A treatment modality consisting of high-dose chemotherapy and bone marrow transplantation for cancer patients who have “failed” one or more protocols. For instance, in Hodgkin lymphoma, 24% of those with long initial remissions survive > 11 years, and thus require further (salvage) therapy (e.g., ABVD—doxorubicin, bleomycin, vinblastine, dacarbazine). Salvage regimens include high-dose chemotherapy (3–10-fold greater than conventional dosage), and may be combined with autologous bone marrow, or peripheral stem cell transplantation. Salvage chemotherapy is problematic as the patients may already be in poor condition, e.g., with severe clinical deterioration; large, bulky, aggressive tumour masses; and multi-drug resistances. Salvage chemotherapy is used in NHL, small cell carcinoma, and Hodgkin lymphoma.

salvage chemotherapy

Oncology A treatment modality consisting of high-dose chemotherapy and BMT, for cancer Pts who have 'failed' one or more protocols. See Heroic therapy.
Mentioned in ?
References in periodicals archive ?
- VANFLYTA[R] (quizartinib) is a FLT3 inhibitor MHLW-approved based on a survival benefit compared to salvage chemotherapy in adult patients with relapsed/refractory FLT3-ITD AML
Daiichi Sankyo Company, Limited - Daiichi Sankyo's VANFLYTA[R] Receives Approval in Japan for the Treatment of Relapsed/Refractory FLT3-ITD AML -- 18/6/2019
The QuANTUM-R study demonstrated that quizartinib resulted in a statistically significant improvement in overall survival compared to salvage chemotherapy when patients were selected with the LeukoStrat CDx FLT3 Mutation Assay.
Japan's MHLW Approves Invivoscribe's LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo's Quizartinib for Treatment of Relapsed/Refractory FLT3-ITD AML. Expands Use to Include Specimens Collected in EDTA
Based on the data from the ADMIRAL trial, treatment with gilteritinib monotherapy versus salvage chemotherapy in adult patients with relapsed or refractory AML with an FLT3 mutation showed that the median Overall Survival for patients who received XOSPATA was 9.3 months compared to 5.6 months for patients who received salvage chemotherapy.
Astellas Pharma Inc wins FDA approval to update XOSPATA label for AML
Targeted Hodgkin's lymphoma therapy with the antibody-drug conjugate Brentuximab vedotin (Bv) has proven to be superior to conventional salvage chemotherapy and clinical trials are being conducted to incorporate Bv into frontline therapy that substitutes Bv for alkylating agents to minimize secondary malignancies.
Retrospective analysis of baseline Prognostic factors on the outcome of Paediatric Hodgkin's Lymphoma in a tertiary care cancer center
This trial is evaluating the impact that the addition of targeted internalized radiation via Actimab-A to the salvage chemotherapy regimen CLAG-M will have on safety and tolerability, response rates, rates of BMT or bone marrow transplant, PFS or progression-free survival, and OS or overall survival.
Actinium Pharmaceuticals begins second dosing cohort of leukemia candidate
Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma.
PROGNOSTIC VALUE OF AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA--A SINGLE CENTRE EXPERIENCE/PROGNOSTICKI ZNACAJ STAROSNO USKLADENOG MEDUNARODNOG PROGNOSTICKOG INDEKSA KOD PACIJENATA SA REFRAKTORNIM DIFUZNIM B KRUPNOCELIJSKIM LIMFOMOM--ISKUSTVO JEDNOG CENTRA
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: A subset analysis of the Canadian cancer trials group LY.12 randomized phase 3 study.
Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
She was started on salvage chemotherapy with high dose Cytarabine plus Mitoxantrone (high-dose AraC and Mitoxantrone protocol).
Uterine Mass and Menorrhagia: A Rare Presentation of Acute Myeloid Leukemia with Arduous Clinical Course
Among patients with cisplatin-resistant disease, Feldman and colleagues discuss the ongoing clinical trial of conventional-dose salvage chemotherapy versus high-dose chemotherapy with stem cell support (NCT02375204) and the background literature supporting the need for this important trial.
Germ Cell Tumors: Updates on Epidemiology, Biology, and Treatment Considerations
Hagenbeeket al., "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma," New England Journal of Medicine, vol.
Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Children and Young Adults with Relapsed Ewing's Sarcoma: A Systematic Review
At this point, he was considered a candidate for high-dose therapy with stem cell transplant if induced into remission and, with this intention, had started salvage chemotherapy with Rituximab/Gemcitabine/Cisplatin/Dexamethasone.
Acute Left Internal Carotid Artery and Right Popliteal Artery Occlusion Related to Cisplatin-Gemcitabine Based Chemotherapy

Medical browser ?
Full browser ?